NeuroSearch

NeuroSearch A/S (NEUR) was founded in 1989 and is listed on the stock exchange in Copenhagen (NASDAQ Copenhagen A/S).

In the period until 2012, the Company was involved in research and development activities with a view to bringing pharmaceuticals to market, primarily in the CNS segment. In 2012, following a number of failed initiatives and projects, the Company realised that it saw no longer feasible to obtain funding to continue operations. As a result, the Board of Directors resolved a plan to wind up the Company. This plan has now been successfully completed as the Company has wound up all activities and all assets except for cash of about DKK 70 million, the value of a tax loss and of its stock exchange listing.

In August 2018, Nordic Transport Group Holding (NTG Holding) became a major shareholder after obtaining an ownership interest of 22.54% in the Company following a takeover offer. NTG Holding has announced plans to merge the Company with Nordic Transport Group A/S, which requires the approval of the Company's shareholders at a general meeting.

For more details about the Company, please see Annual Report 2017 and subsequent company announcements.

Cookiepolicy

Nordic Transport Group Holding A/S

DISCLAIMER

This website provides access to viewing, reading and downloading an offer document (the “NTG Offer Document”) prepared by Nordic Transport Group Holding A/S (“NTG Holding”) in connection with a voluntary, public takeover offer to the shareholders of NeuroSearch A/S (“NeuroSearch”).

Neither the content of nor any links on this website is or shall be deemed to be part of the NTG Offer Document.

If you are resident in another jurisdiction than Denmark, please read carefully the below:

The release of the NTG Offer Document may be restricted by law or may not be permitted in certain jurisdictions. Anyone wanting to download or access the NTG Offer Document from this website is required to inform themselves about and to observe any applicable legal and regulatory restrictions of their jurisdictions prior to such downloading or access.

Persons subject to such restrictions, including, inter alia, persons residing in the United States of America, Canada, Australia, Japan, Hong Kong or South Africa, are not authorized to access or receive the NTG Offer Document or to obtain information regarding the voluntary, public takeover offer to the shareholders of NeuroSearch.

By clicking the "I confirm"-button below I confirm:

that I want access to the NTG Offer Document,

that it is my responsibility to have examined and observed any and all restrictions that may apply, and

that I am not in, residing in or have access to the NTG Offer Document from the United States of America, Canada, Australia, Japan, Hong Kong or South Africa or any other jurisdiction where release of the NTG Offer Document is restricted and/or where the voluntary, public takeover offer to the shareholders of NeuroSearch is not permitted to be conducted.

The use of this website is subject to Danish law and any disputes arising out of or regarding this website and the access to the NTG Offer Document is subject to the exclusive jurisdiction of the Danish courts.